Autocrine IGF signaling supports progression of the CML blast crisis phase, and, conversely, inhibition of IGF-1R reduces viability and proliferation of BCR-ABL+ cells [20]. The gene discussed is IGF1R; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.